1,250
Views
8
CrossRef citations to date
0
Altmetric
Review

Beyond abiraterone

New hormonal therapies for metastatic castration-resistant prostate cancer

Pages 149-155 | Received 28 Apr 2013, Accepted 06 Oct 2013, Published online: 01 Nov 2013

Figures & data

Figure 1. Summarized view of androgen receptor cross-talk with other pathways. AR, androgen receptor; TyrK, tyrosine-kinase receptor; IL-6R, interleukin-6 receptor.

Figure 1. Summarized view of androgen receptor cross-talk with other pathways. AR, androgen receptor; TyrK, tyrosine-kinase receptor; IL-6R, interleukin-6 receptor.

Figure 2. Mechanisms involved on prostate carcinoma initation and progression. AR, androgen receptor; PTMs, posttranslational modifications.

Figure 2. Mechanisms involved on prostate carcinoma initation and progression. AR, androgen receptor; PTMs, posttranslational modifications.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.